Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Share
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA -
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
How Holistic IT Strategies Drive Mission Outcomes
Former GSA associate CIO Erika Dinnie shares lessons on holistic modernization and offers practical guidance for federal employees exploring private sector opportunities.
5m watch -
CIOs Leverage Cloud to Unify Behavioral Health Services
CIOs shared how standardized infrastructure and real-time data capabilities are improving patient tracking, reporting and operational efficiency.
3m read -
Marne Innovation Center Empowers Soldiers to Solve Battlefield Challenges
The Army’s Marne Innovation Center is transforming battlefield efficiency by sourcing real-time problems and solutions directly.
12m listen -
From Fed to Founder: Joe Scheidler on People, Policy, Innovation
Joe Scheidler outlined lessons from his White House and State Department tenure that helped drive his startup success.
7m watch
